Jade Biosciences (JBIO) Interest Coverage Ratio (2020 - 2026)
Jade Biosciences (JBIO) posted Interest Coverage Ratio of 40.99 for Q1 2026, down 4283.38% on a QoQ basis from 0.94 in Q3 2025, and down 390.76% year-over-year from 14.1 in Q1 2025.
Jade Biosciences (JBIO) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Jade Biosciences' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 40.99 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 390.76% year-over-year to 40.99 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 126.04 (down 256.8% YoY) and the FY2025 annual result came in at 31.54, down 219.47% from the prior year.
- Interest Coverage Ratio was 40.99 for Q1 2026 at Jade Biosciences, down from 0.94 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 226.46 in Q4 2022 and bottomed at 1296.25 in Q3 2024.
- A 5-year average of 89.78 and a median of 0.68 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 99.99% — and 2024, when it tumbled 107571.01%.
- Jade Biosciences' Interest Coverage Ratio stood at 226.46 in 2022, then sank by 181.88% to 185.43 in 2023, then tumbled by 599.06% to 1296.25 in 2024, then soared by 99.93% to 0.94 in 2025, then slumped by 4283.38% to 40.99 in 2026.
- Business Quant data shows JBIO's Interest Coverage Ratio at 40.99 in Q1 2026, 0.94 in Q3 2025, and 0.66 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | -40.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.99 |
| Sep 30, 2025 | -0.94 |
| Jun 30, 2025 | -0.66 |
| Mar 31, 2025 | -8.35 |
| Sep 30, 2024 | -1,296.25 |
| Jun 30, 2024 | -36.85 |
| Mar 31, 2024 | -0.26 |
| Dec 31, 2023 | -185.43 |
| Sep 30, 2023 | -1.20 |
| Jun 30, 2023 | -0.68 |
| Mar 31, 2023 | -0.41 |
| Dec 31, 2022 | 226.46 |
| Sep 30, 2022 | -0.41 |
| Jun 30, 2022 | -0.39 |
| Mar 31, 2022 | -0.27 |
| Dec 31, 2021 | 8,268.00 |
| Sep 30, 2021 | -0.15 |
| Jun 30, 2021 | -0.12 |
| Mar 31, 2021 | -2,780.00 |
| Dec 31, 2020 | 50.88 |